These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 14975585

  • 1. Deficient p75 low-affinity neurotrophin receptor expression exacerbates experimental allergic encephalomyelitis in C57/BL6 mice.
    Copray S, Küst B, Emmer B, Lin MY, Liem R, Amor S, de Vries H, Floris S, Boddeke E.
    J Neuroimmunol; 2004 Mar; 148(1-2):41-53. PubMed ID: 14975585
    [Abstract] [Full Text] [Related]

  • 2. Deficient p75 low-affinity neurotrophin receptor expression does alter the composition of cellular infiltrate in experimental autoimmune encephalomyelitis in C57BL/6 mice.
    Küst B, Mantingh-Otter I, Boddeke E, Copray S.
    J Neuroimmunol; 2006 May; 174(1-2):92-100. PubMed ID: 16519950
    [Abstract] [Full Text] [Related]

  • 3. Targeted expression of IGF-1 in the central nervous system fails to protect mice from experimental autoimmune encephalomyelitis.
    Genoud S, Maricic I, Kumar V, Gage FH.
    J Neuroimmunol; 2005 Nov; 168(1-2):40-5. PubMed ID: 16120466
    [Abstract] [Full Text] [Related]

  • 4. Increased thrombin inhibition in experimental autoimmune encephalomyelitis.
    Beilin O, Karussis DM, Korczyn AD, Gurwitz D, Aronovich R, Hantai D, Grigoriadis N, Mizrachi-Kol R, Chapman J.
    J Neurosci Res; 2005 Feb 01; 79(3):351-9. PubMed ID: 15605378
    [Abstract] [Full Text] [Related]

  • 5. Gene expression analysis suggests that 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by stimulating inflammatory cell apoptosis.
    Spach KM, Pedersen LB, Nashold FE, Kayo T, Yandell BS, Prolla TA, Hayes CE.
    Physiol Genomics; 2004 Jul 08; 18(2):141-51. PubMed ID: 15138306
    [Abstract] [Full Text] [Related]

  • 6. Anti-IL-16 therapy reduces CD4+ T-cell infiltration and improves paralysis and histopathology of relapsing EAE.
    Skundric DS, Dai R, Zakarian VL, Bessert D, Skoff RP, Cruikshank WW, Kurjakovic Z.
    J Neurosci Res; 2005 Mar 01; 79(5):680-93. PubMed ID: 15682385
    [Abstract] [Full Text] [Related]

  • 7. VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE.
    Roscoe WA, Welsh ME, Carter DE, Karlik SJ.
    J Neuroimmunol; 2009 Apr 30; 209(1-2):6-15. PubMed ID: 19233483
    [Abstract] [Full Text] [Related]

  • 8. The influence of uric acid treatments on liver glutathione system prevent oxidative damages in experimental autoimmune encephalomyelitis mice.
    Allameh A, Maleklou N, Zargari M, Sanati MH.
    Neurosci Lett; 2008 Jul 04; 439(1):111-5. PubMed ID: 18501514
    [Abstract] [Full Text] [Related]

  • 9. Overexpression of CNTF in Mesenchymal Stem Cells reduces demyelination and induces clinical recovery in experimental autoimmune encephalomyelitis mice.
    Lu Z, Hu X, Zhu C, Wang D, Zheng X, Liu Q.
    J Neuroimmunol; 2009 Jan 03; 206(1-2):58-69. PubMed ID: 19081144
    [Abstract] [Full Text] [Related]

  • 10. Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE).
    Olechowski CJ, Truong JJ, Kerr BJ.
    Pain; 2009 Jan 03; 141(1-2):156-64. PubMed ID: 19084337
    [Abstract] [Full Text] [Related]

  • 11. Elevated interferon gamma expression in the central nervous system of tumour necrosis factor receptor 1-deficient mice with experimental autoimmune encephalomyelitis.
    Wheeler RD, Zehntner SP, Kelly LM, Bourbonnière L, Owens T.
    Immunology; 2006 Aug 03; 118(4):527-38. PubMed ID: 16780563
    [Abstract] [Full Text] [Related]

  • 12. CD62L is required for the priming of encephalitogenic T cells but does not play a major role in the effector phase of experimental autoimmune encephalomyelitis.
    Li O, Liu JQ, Zhang H, Zheng P, Liu Y, Bai XF.
    Scand J Immunol; 2006 Aug 03; 64(2):117-24. PubMed ID: 16867156
    [Abstract] [Full Text] [Related]

  • 13. Absence of PAF receptor alters cellular infiltrate but not rolling and adhesion of leukocytes in experimental autoimmune encephalomyelitis.
    Rodrigues DH, Lacerda-Queiroz N, de Miranda AS, Fagundes CT, Campos RD, Arantes RE, Vilela Mde C, Rachid MA, Teixeira MM, Teixeira AL.
    Brain Res; 2011 Apr 18; 1385():298-306. PubMed ID: 21338585
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis.
    Noorbakhsh F, Tsutsui S, Vergnolle N, Boven LA, Shariat N, Vodjgani M, Warren KG, Andrade-Gordon P, Hollenberg MD, Power C.
    J Exp Med; 2006 Feb 20; 203(2):425-35. PubMed ID: 16476770
    [Abstract] [Full Text] [Related]

  • 16. Genetic deletion of Fatty Acid Amide Hydrolase results in improved long-term outcome in chronic autoimmune encephalitis.
    Webb M, Luo L, Ma JY, Tham CS.
    Neurosci Lett; 2008 Jul 04; 439(1):106-10. PubMed ID: 18501510
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. PPARgamma antagonists exacerbate neural antigen-specific Th1 response and experimental allergic encephalomyelitis.
    Raikwar HP, Muthian G, Rajasingh J, Johnson C, Bright JJ.
    J Neuroimmunol; 2005 Oct 04; 167(1-2):99-107. PubMed ID: 16091293
    [Abstract] [Full Text] [Related]

  • 19. Downregulation of membrane type-matrix metalloproteinases in the inflamed or injured central nervous system.
    Toft-Hansen H, Babcock AA, Millward JM, Owens T.
    J Neuroinflammation; 2007 Sep 20; 4():24. PubMed ID: 17883829
    [Abstract] [Full Text] [Related]

  • 20. Soluble egg antigen from Schistosoma japonicum modulates the progression of chronic progressive experimental autoimmune encephalomyelitis via Th2-shift response.
    Zheng X, Hu X, Zhou G, Lu Z, Qiu W, Bao J, Dai Y.
    J Neuroimmunol; 2008 Feb 20; 194(1-2):107-14. PubMed ID: 18207251
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.